NLPC Associate Fellow Mark Modica appeared Wednesday on Cavuto on Fox Business Network to discuss the new "partnership" between the Environmental Protection Agency (EPA) and the National Association for Stock Car Auto Racing (NASCAR). Here's a transcript:
The Securities and Exchange Commission recently notified us that it will allow Goldman Sachs to exclude our shareholder proposal that asks for a report on the company's lobbying priorities. The basis for the exclusion was that another shareholder, The Needmoor Fund, had already submitted a similar proposal. We disagree that the proposals duplicate each other. We hope that Needmoor will raise the issues that prompted our proposal, especially Goldman's endorsement of Dodd-Frank, but we doubt they will.
Today's headlines that Jon Corzine gave "direct instructions" for MF Global customer money to be moved to another account to cover a $175 million overdraft raises big questions about how this case is being handled. Congressional Committee's are imperfect investigative vehicles, but this time the House Financial Services Subcommittee on Oversight and Investigation has really scored. By digging out and making public an email from MF Global assistant treasurer Edith O'Brien, the Committee has done a huge public service.
In a major victory for the National Legal and Policy Center, the Federal Communications Commission (FCC) yesterday reversed itself and revoked a controversial waiver it had granted LightSquared, which would have allowed the company to deploy a national wireless network. The reversal is not only a major setback for LightSquared's billionaire owner Phil Falcone, but puts a harsh spotlight on the role of FCC Chairman Julius Genachowski.
In a recent interview with the "City and State" website, which covers New York politics, Rep. Gregory Meeks (D-NY) said that he wants "to go after" our not-for-profit status. The threat was part of a more general attack on the New York Post, which has published a series of articles based on information we have provided. We have also provided information to the New York Times and New York Daily News. All the headlines have led to a House Ethics Committee investigation, and reportedly, a grand jury investigation of Meeks' finances.
Authored by Carl Horowitz, director of NLPC's Organized Labor Accountability Project, this Special Report examines the effect labor unions have on the workforce. As the recent events in Wisconsin showed, labor unions and their political alliies are as influential as ever. Unless major changes are made to the ways they function within the public sector, they'll continue to undermine any economic recovery.
Billionaire Phil Falcone, whose cozy relationship with the Obama Administration was first exposed by NLPC, may face civil fraud charges by the Securities and Exchange Commission (SEC). According to a filing yesterday by Harbinger Group Inc., Falcone and two other directors have received "Wells Notices," meaning that they are under investigation.
Falcone is the Chairman, CEO and primary investor in Harbinger Group Inc., a hedge fund. Reportedly, other Harbinger investors include Soros Fund Management. Harbinger owns LightSquared, which has received an unusual waiver from the Federal Communications Commission (FCC) to deploy a national 4G wireless network.
The National Legal and Policy Center (NLPC) today filed a formal request under the Freedom of Information Act (FOIA) with the National Highway Traffic Safety Administration (NHTSA) for any and all communications with General Motors (GM).
The NHTSA is investigating three fires in the battery packs of GM's Chevy Volt following collision tests, but may have withheld information of this potential safety problem from the public for several months.
NLPC has filed a shareholder proposal challenging Pfizer's support for ObamaCare. The resolution actually asks for a report on Pfizer's lobbying priorities. Here is the supporting statement submitted to Pfizer for inclusion in the proxy:
Pfizer played a key role in the passage of ObamaCare, even though a majority of Americans were opposed. CEO Jeffrey Kindler organized pharmaceutical CEOs in support of the bill, promoted a massive advertising campaign, and partnered with Left-wing groups normally hostile to Pfizer's interests. For these actions, he received a multi-million dollar bonus.